Actively Recruiting
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
Led by China Medical University Hospital · Updated on 2024-07-03
50
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial used acupuncture as an adjunctive treatment for glaucoma patients. A randomized, controlled trial involving 50 subjects will be conducted and observed for 12 weeks to evaluate the clinical efficacy of acupuncture. This study aims to provide a reference for future clinical treatment guidelines.
CONDITIONS
Official Title
Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary open angle glaucoma diagnosed at least 3 months ago.
- Diagnosed with mild or moderate open angle glaucoma.
- Using one or two kinds of glaucoma drugs.
- Age 20 years or older.
- Signed informed consent and willing to cooperate with study procedures.
You will not qualify if you...
- Received any eye laser or surgery within the past year.
- Have high myopia.
- Use any drugs that affect intraocular pressure.
- Visual acuity with correction lower than 0.2.
- Have previous or current uveitis or retinopathy.
- Unable to receive acupuncture continuously or allergic to acupuncture needles.
- Pregnant or breastfeeding.
- Refuse to sign the informed consent form.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Medical University Hospital
Taichung, Taiwan
Actively Recruiting
Research Team
L
LEE YU-CHEN, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here